Phase 3 study for patients with GERD - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if the study drug (IW-3718) is safe and will work in reducing gastroesophageal reflux symptoms when you are still taking your proton pump inhibitor medicine.
Who Can Participate in the Study?
- Are currently taking a proton pump inhibitor medication (PPI) and still experiencing reflux/GERD symptoms at least 4 times a week
- Are willing to undergo an EGD and Bravo placement
What is Involved?
If you choose to join this study, you will:
- Have an ECG
- Have several blood and urine tests including a drug screen
- Have a physical exam
- Have a esophogastroduodenoscopy (EGD: a scope that is placed to see inside your esophagus and stomach) with Bravo capsule placement that will record your stomach acid levels
- Complete questionnaires